Join us tomorrow night...
| |
Dear Reader,
Tomorrow night, I will join Dr. David Eifrig and Dave Lashmet for an incredibly important, live event.
We're going to be covering a difficult topic, cancer, and the latest breakthrough cancer treatments (even the ones your doctors legally can’t talk about yet). Then we'd like to show you how these treatments could lead to amazing investment opportunities.
In fact, tomorrow night, we'll show you the best ways to invest in biotech companies that can make you 2x, 3x, or even up to 5x your money.
What: Stansberry Research's First-Ever Cancer Briefing
When: Tomorrow, November 15th, 8 pm ET
Where: Click here to reserve your seat.
Please, do yourself a favor and sign up to attend this event. The information alone will be worth an hour of your time, and we'll send you a free report just for attending. Click the banner below to learn more & reserve your seat.
See you tomorrow night,
Jared Kelly
Managing Director and Host
Stansberry Research's First-Ever Cancer Briefing
|
|
| |
All contents of this e-mail are copyright 2017 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.
DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.
You're receiving this email at [email protected]. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to [email protected].
To unsubscribe from this mailing, click here: Unsubscribe
|
|
|
